Insmed Inc. buy Guggenheim
Start price
18.12.25
/
50%
€142.00
Target price
18.12.26
€188.27
Performance (%)
-14.66%
Price
09:47
?
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -14.66%. This prediction currently runs until 18.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -5.109% | -5.109% |
| iShares Core DAX® | 0,44 % | 3,03 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % |
| iShares S&P 500 | 2,37 % | 2,68 % |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Guggenheim from $230.00 to $221.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat